Mark A. Socinski, MD - Global Perspectives on Biomarker Testing in NSCLC: Clinical Insights on Optimizing Implementation in Practice

episode

CME in Minutes: Education in Primary Care not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Soup 56 min · 23 Sep 2026 · Three Bean Salad

AFL Record Editor Ash Browne | Grand Final edition on sale now! (23.09.26) 2 min · 23 Sep 2026 · Whateley

Send Me To Sleep | Aristotle 44 min · 23 Sep 2026 · Send Me To Sleep

Finding the balance between offence & defence | The Art of Coaching with Ken Hinkley! (23.09.26) 5 min · 23 Sep 2026 · Whateley

US-Iran Teams Meet, Markets Weigh AI Trade, More 8 min · 23 Sep 2026 · Bloomberg News Now

8PM ET 09/22/2026 Newscast 3 min · 23 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded24 Jun 2025

Publisherc.answersincme.com ↗

Handlerec:10296237

Show notes

Please visit answersincme.com/ZDE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in lung cancer discusses best practices for implementing biomarker testing in non-small cell lung cancer (NSCLC) management. Upon completion of this activity, participants should be better able to: Apply current guideline recommendations for biomarker testing to the management of patients with NSCLC, Outline practical strategies within the multidisciplinary team to optimize biomarker testing for patients with NSCLC; and Discuss methods to link biomarker testing to treatment decision-making for patients with NSCLC.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in